[Federal Register Volume 68, Number 19 (Wednesday, January 29, 2003)]
[Notices]
[Page 4494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-1999]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC): Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    Name: Healthcare Infection Control Practices Advisory Committee.
    Time and Date: 10 a.m.-6 p.m., February 3, 2003.
    Place: Crowne Plaza Atlanta Airport, 1325 Virginia Avenue, Atlanta, 
GA 30344.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Infectious 
Diseases (NCID), regarding (1) the practice of hospital infection 
control; (2) strategies for surveillance, prevention, and control of 
infections (e.g., nosocomial infections), antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of guidelines and other policy statements regarding 
prevention of healthcare associated infections and healthcare-related 
conditions.
    Matters To Be Discussed: Agenda items will include infection 
control precautions for patients with vaccinia-related adverse events 
and respiratory protection options for healthcare workers potentially 
exposed to patients with pneumonic plague and smallpox.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Michele L. Pearson, M.D., 
Executive Secretary, HICPAC, Division of Healthcare Quality Promotion, 
NCID, CDC, 1600 Clifton Road, NE, M/S A-07, Atlanta, Georgia 30333, 
telephone 404-498-1182.
    Due to programmatic issues that had to be resolved, the Federal 
notice is being published less than fifteen days before the date of 
meeting.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: January 23, 2003.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 03-1999 Filed 1-28-03; 8:45 am]
BILLING CODE 4163-18-P